Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population displaying relapsing-remitting experimental autoimmune encephalomyelitis at a point in time
go back to main search page
Accession:CMO:0001403 term browser browse the term
Definition:The number of individuals in a study population which display relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE) at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage. R-EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells where such induction results in a disease characterized by repeated symptomatic attacks followed by complete or almost complete improvement.
Synonyms:exact_synonym: percentage of study population displaying relapsing/remitting experimental autoimmune encephalomyelitis at a point in time
 related_synonym: R-EAE prevalence;   relapsing-remitting EAE prevalence;   relapsing-remitting experimental autoimmune encephalomyelitis prevalence



show annotations for term's descendants           Sort by:

Term paths to the root